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PAdult Congenital Heart Disease
Follow-Up After Pulmonary Valve Replacement
in Adults With Tetralogy of Fallot
Association Between QRS Duration and Outcome
Roderick W. C. Scherptong, MD,* Mark G. Hazekamp, MD, PHD,†‡ Barbara J. M. Mulder, MD, PHD,§
Olivier Wijers, MSC,* Cees A. Swenne, PHD,* Ernst E. van der Wall, MD, PHD,*
Martin J. Schalij, MD, PHD,* Hubert W. Vliegen, MD, PHD*
Leiden, Amsterdam, and Utrecht, the Netherlands
Objectives The aim of this study was to analyze whether QRS duration, before and after pulmonary valve replacement
(PVR), is related to long-term outcome in patients with tetralogy of Fallot (TOF).
Background Key factors that determine outcome after PVR in adult TOF patients are largely unknown. Recognition of such
factors assists the identification of patients at increased risk of adverse events.
Methods Adults who previously underwent total correction for TOF (n  90; age 31.4  10.3 years) and required PVR for
pulmonary regurgitation were included. The QRS duration was measured pre-operatively and 6 months after
PVR. The post-operative changes in QRS duration were calculated. Adverse events (death, re-PVR, ventricular
tachycardia, and symptomatic heart failure) were noted during follow-up.
Results During 5.5  3.5 years of follow-up, 13 adverse events occurred. The 5-year event-free survival rate was 76% for
patients with a pre-operative QRS duration 180 ms and 90% in patients with a QRS duration 180 ms (p 
0.037). For patients with a post-operative QRS duration 180 ms, 5-year event-free survival was 71%, whereas
it was 91% for patients with a post-operative QRS duration 180 ms (p  0.004). After multivariate correction,
a post-operative QRS duration 180 ms (hazard ratio: 3.685, 95% confidence interval: 1.104 to 12.304, p 
0.05) and the absence of a reduction in QRS duration post-PVR (hazard ratio: 6.767, 95% confidence interval:
1.704 to 26.878, p  0.01), was significantly associated with adverse outcome.
Conclusions Severe QRS prolongation, before or after PVR, and the absence of a reduction in QRS duration after PVR, are
major determinants of adverse outcome during long-term follow-up of patients with TOF. (J Am Coll Cardiol
2010;56:1486–92) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.04.058f
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arogressive pulmonary regurgitation (PR) is a common
omplication after total surgical correction of tetralogy of
allot (TOF) (1). Long-standing PR leads to right ventric-
lar (RV) dilation, which in turn causes RV dysfunction and
educed exercise tolerance (2,3). Pulmonary valve replace-
ent (PVR) provides an adequate surgical therapy for PR as
t leads to improvement of RV function and the patient’s
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Manuscript received December 31, 2009; revised manuscript received March 10,
010, accepted April 13, 2010.unctional class (4). Numerous studies have indicated the
eneficial effects of PVR in terms of improvement of RV
olume and ejection fraction shortly after PVR (5–7). In
ddition, it was demonstrated that RV depolarization and
epolarization characteristics improve after PVR, partly
n response to the reduction in RV volumes (8,9).
pecifically, QRS duration, which is strongly associated
ith RV function and prognosis in TOF (10), tends to
educe after PVR (8). In addition, it is known that TOF
atients with severely prolonged QRS duration (180 ms) are
t risk for adverse events (11). Nevertheless, it is unclear
hether an association exists between, on the one hand,
re-PVR QRS duration and post-PVR changes in QRS
uration and, on the other hand, long-term outcome after
VR. Consequently, the clinical relevance of pre- and
ost-PVR QRS duration, and of changes in QRS duration
fter PVR, is presently unknown. The current study aimed
o assess how pre-operative QRS duration and post-
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October 26, 2010:1486–92 Long-Term Outcome After PVR in TOF Patientsperative changes in QRS duration are related to outcome
uring long-term follow-up after PVR in TOF patients.
ethods
tudy population. In a prospective, multicenter cohort
tudy, adult patients after prior total repair for TOF, who
ad undergone a PVR for PR, were followed up (12,13). In
ll patients, primary surgical repair was performed during
hildhood. The indications for PVR were moderate to
evere PR in combination with RV dilation and impaired New
ork Heart Association (NYHA) functional class (4). A
tandard 12-lead electrocardiogram (ECG) was obtained im-
ediately before and 6 months after PVR. If an ECG was not
vailable at 1 of the time points, patients were excluded from
urther analysis. All patients were followed up annually at the
ut-patient clinic, and the occurrence of adverse events was
oted during follow-up after PVR. Adverse events were
efined as death due to any cause, reoperation for recurrent
ulmonary regurgitation, symptomatic heart failure, and ven-
ricular arrhythmias.
urgical procedures. The PVR was performed through
edian sternotomy. After release of adhesions, total cardio-
ulmonary bypass was started. A cryopreserved pulmonary
omograft was implanted, usually on beating heart. If
ecessary, small residual ventricular septal defects were
uture closed, and right ventricular outflow tract (RVOT)
econstruction was performed as described previously (12).
n addition, when pre-operative assessment revealed signif-
cant tricuspid regurgitation, tricuspid annuloplasty was
erformed (14).
lectrocardiographic analysis. Electrocardiograms were
tored digitally and exported from the ECG database manage-
ent system for off-line analysis with the MATLAB-based
The MathWorks, Natick, Massachusetts) computer pro-
ram LEADS (Leiden, the Netherlands). Details about the
alculation methods used in LEADS have been reported
reviously (15). The software averages a digitized version of
he standard 12-lead surface ECG into a representative
ingle-beat ECG in which all 12 leads are superimposed.
he software is equipped with a cross-hair editor interface
hat allows magnification of the ECG, and thereby facili-
ates accurate measurement of QRS duration according to
he Minnesota criteria for population-based ECG studies
8). All ECGs were analyzed by a single observer blinded to
he patient’s clinical status and operation results. The cut-off
or severely prolonged QRS duration was set at 180 ms
10,11).
tatistical analysis. The SPSS version 16.0.2 software
SPSS, Inc., Chicago, Illinois) was used for statistical
nalysis. GraphPad Prism 4.00 for Windows (GraphPad
oftware, La Jolla, California) was used to obtain life tables
nd corresponding Kaplan-Meier survival curves.
First, pre- and post-operative QRS duration and NYHA
unctional class were compared using a paired t test. Second,
he association between QRS duration and the occurrence 3f adverse events during post-
perative follow-up was assessed
sing Cox’s proportional hazards
egression analysis. Univariate
azard ratios (HR) were calculated
ith corresponding 95% confi-
ence interval (CI) for the fol-
owing variables: 1) pre- and post-
perative QRS duration as a
ontinuous variable, in ms; 2) pre-
nd post-operative QRS duration
s a categorical variable, 180 or
180 ms; 3) changes in QRS dura-
ion, from pre- to post-operative,
s a continuous variable, in ms;
nd 4) changes in QRS duration,
rom pre- to post-operative, as a
ategorical variable, expressed as
he presence or the absence of reduction in QRS duration.
fterward, the HRs were adjusted for age at PVR (below or
bove the median age of 30 years) and the presence of
oncomitant procedures during PVR, to obtain the multivar-
ate HRs.
Third, the annualized event rates were assessed in patient
ubgroups on the basis of the pre- and post-operative QRS
urations (180 or 180 ms) in addition to the post-
perative changes in QRS duration (reduction or no reduc-
ion). The number of observed events was normalized to
00 patient-years in each subgroup to facilitate comparison
etween groups. Afterward, the 95% CI of the observed
vent rate was calculated, and the difference in event rate
as compared to the overall event rate by assuming that the
umber of observed events has a Poisson distribution.
Finally, to visualize the difference in event-free survival
etween different QRS duration patient categories, Kaplan-
eier curves were drawn and log-rank statistics were
alculated for the following 3 patient subgroups: 1) pre-
perative QRS duration 180 or 180 ms; 2) post-
perative QRS duration 180 or 180 ms; and 3) changes
n QRS duration, expressed as the presence or absence of a
ost-operative reduction in QRS duration. Separate
aplan-Meier curves were obtained in which death, symp-
omatic heart failure, and ventricular arrhythmias were
ncluded as an end point and re-PVR was excluded.
Where appropriate, data are reported as mean  SD, n
%), or as HR (95% CI). All p values0.05 were considered
tatistically significant.
esults
inety-nine consecutive corrected TOF patients who
nderwent PVR at adulthood were considered for the
tudy. Nine patients were excluded because of missing
CGs, and the remaining 90 patients were all included in
he study (Table 1). The PVR was performed at an age of
Abbreviations
and Acronyms
CI  confidence interval
ECG  electrocardiogram
HR  hazard ratio
NYHA  New York Heart
Association
PA  pulmonary artery
PR  pulmonary
regurgitation
PVR  pulmonary valve
replacement
RV  right ventricular
RVOT  right ventricular
outflow tract
TOF  tetralogy of Fallot1.4  10.3 years, and pre-operative NYHA functional
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Long-Term Outcome After PVR in TOF Patients October 26, 2010:1486–92lass was 2.4  0.7. The size of the implanted homografts
as 25.6  1.6 mm, and concomitant surgical proce-
ures, mostly RVOT reconstructions, were required in 42
atients (47%) (Table 1).
linical outcome. No patients were lost to follow-up.
fter PVR, NYHA functional class improved from 2.4 
.7 to 1.3  0.6 (p  0.001). During a mean follow-up
uration of 5.5  3.5 years (range 1.1 to 17.9 years), 13
dverse events occurred (Fig. 1A). The observed event-free
ollow-up was 100% at 1 year, 96% at 2 years, 89% at 5
ears, and 78% at 10 years (Fig. 1B). During follow-up, 2
atients died after 1.4 and 8.5 years, respectively, of sudden
ardiac death (first patient) and fast-progressive, therapy
efractory heart failure (second patient). Re-PVR was per-
ormed in 5 patients, and ventricular tachycardia requiring
mplantation of an implantable cardioverter defibrillator
ccurred in 4 patients.
rediction of patient outcome using QRS duration. Be-
ore PVR, QRS duration was 158  29 ms, which reduced
 17 ms to 154  32 ms 6 months after surgery
p  0.027) (Table 1).
Pre-operative NYHA functional class was not associated
ith pre- or post-operative QRS duration or the post-
perative changes in QRS duration (black bars in Fig. 2)
nd demonstrated to improve in all patient groups based on
RS duration (Fig. 2). However, in patients with a QRS
uration 180 ms, either pre- or post-operative, a less
rominent improvement in NYHA functional class was
atient Population (n  90)Table 1 Patient Population (n  90)
Sex
Male 53 (59)
Female 37 (41)
Characteristics of initial repair
Age, yrs 5.8 5.5
Transannular patch 62 (69)
RV patch 9 (10)
RV to PA conduit 5 (6)
No patch 14 (16)
Characteristics of PVR
Pre-operative NYHA functional class 2.4 0.7
Age, yrs 31.4 10.3
Homograft diameter, mm 25.6 1.6
Concomitant procedures
Patients with concomitant procedures 42 (47)
Ventricular septal defect closure 2 (2)
RVOT reconstruction 27 (30)
Tricuspid valvuloplasty 17 (19)
QRS duration
Pre-operative, ms 158 29
Changes from pre- to post-operative, ms 4 17*
Post-operative, ms 154 32
alues are n (%) or mean SD. *p 0.027 for the difference between pre- and post-operative QRS
uration.
NYHA  New York Heart Association; PA  pulmonary artery; PVR  pulmonary valve
eplacement; RV  right ventricular; RVOT  right ventricular outflow tract.bserved as compared to patients with a QRS duration180 ms pre-operatively (p  0.002) or post-operatively
p  0.045).
Both pre- and post-operative QRS durations, as well as
ost-operative change in QRS duration, were significantly
ssociated with adverse outcome after PVR (Table 2). The
rude HRs of pre- and post-operative QRS duration were
.025 and 1.026, respectively, per ms increase in QRS
uration. This indicated that a longer QRS duration either
re- or post-operatively was associated with a higher inci-
ence of adverse events. Furthermore, the change in QRS
uration from pre-operatively to 6 months after PVR was
lso related to post-operative outcome. The crude HR for
he occurrence of adverse events was 0.978 per ms change in
RS duration, demonstrating that a post-operative reduc-
ion in QRS duration was associated with a lower incidence
f adverse events during follow-up. After multivariate cor-
ection, pre- and post-operative QRS duration and post-
perative changes in QRS duration remained significantly
elated to the incidence of adverse events. Specifically, a
ost-operative QRS duration 180 ms or the lack of a
eduction in QRS duration post-operatively were strong
A
B
Figure 1 Patient Population and Follow-Up Characteristics
(A) Overview of the events that occurred during follow-up of the study popula-
tion, and (B) the overall Kaplan-Meier survival curve of the patients. The num-
bers below signify patients at risk. HF  heart failure; PAR  patients at risk;
PVR  pulmonary valve replacement; VT  ventricular tachycardia.
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October 26, 2010:1486–92 Long-Term Outcome After PVR in TOF Patientsredictors of adverse events, with multivariate HRs of 3.685
nd 6.767, respectively.
To further explore the association between QRS duration
nd event-free survival after PVR, the study population was
ubdivided based on QRS duration (pre- and post-
perative; 180 or 180 ms), and post-operative change in
RS duration (reduction or no reduction), which yielded 8
ubgroups (Table 3). Subsequently, the annualized event
ate, normalized to 100 patient-years, was calculated for the
verall study population and for the 8 subgroups (Table 3).
he overall event rate in the study population was 2.7 (95%
I: 1.4 to 4.6) per 100 patient-years. No events were
bserved among patients with a pre-operative QRS duration
Figure 2 NYHA Functional Class and QRS Duration
Mean pre-operative (solid bars) and post-operative (open bars) New York Heart
Association (NYHA) functional class (y-axis) depicted in relation to (x-axis) (A)
pre-operative QRS duration, (B) post-operative changes in QRS duration, and
(C) QRS durations 6 months post-operative.180 ms who demonstrated a post-operative reduction in dRS duration (n  44). On the contrary, a significantly
igher event rate was observed among patients who did not
emonstrate a reduction in QRS duration and had a QRS
uration 180 ms, either pre-operatively or post-
peratively. In those groups, the event rates were 20.6 events
95% CI: 2.5 to 74.5; p  0.007 vs. the overall population)
nd 9.3 events (95% CI: 2.5 to 23.8; p  0.030 vs. the
verall population) per 100 patient-years (Table 3).
The Kaplan-Meier survival curves (Fig. 3) confirmed that
atients with significantly prolonged QRS duration (180 ms)
emonstrated worse event-free survival as compared with that
f patients with a QRS duration 180 ms. The observed
-year event-free survival was 76% for patients with a pre-
perative QRS duration 180 ms as compared with 90% for
atients with a QRS duration180 ms (p 0.037) (Fig. 3A).
he observed 5-year event-free survival was 71% for patients
ith a post-operative QRS duration 180 ms as compared
ith 91% for patients with a QRS duration 180 ms (p 
.003) (Fig. 3E). Furthermore, 5-year event-free survival of
atients in whom no reduction in QRS duration was observed
months after PVR was worse as compared with that of
atients who had a reduction in QRS duration after PVR. The
bserved difference in event-free survival between those 2
roups was 24.5% at 5 years (p  0.004) (Fig. 3C). Exclusion
f re-PVR as an end point in the Kaplan-Meier survival curve
emonstrated that event-free survival was 4.1% lower in
atients with a pre-operative QRS duration 180 ms as
ompared to 180 ms, which was not statistically significant
p 0.61) (Fig. 3B). The Kaplan-Meier curve, in which the
atient population was stratified according to post-operative
RS duration (180 or 180 ms) or post-operative
hanges in QRS duration (reduction or no reduction), was
imilar whether or not re-PVR was excluded as an end point
Figs. 3D and 3F).
iscussion
he main findings of this study were: 1) a QRS duration
180 ms, either pre- or post-operatively, or the lack of a
eduction in QRS duration after PVR, was significantly asso-
iated with adverse outcome after PVR; and 2) the highest
ncidence of adverse events was observed among patients with
severely prolonged QRS duration either pre- or post-
peratively, without a reduction in QRS duration after PVR.
Progressive PR is one of the most common complications
fter total surgical repair of TOF. In response to the
egurgitated volume, the RV dilates to overcome the in-
reased loading conditions (1,16). Long-standing PR will
ventually lead to dysfunction of the RV, and patients may
xperience reduced exercise tolerance (17). In such cases,
VR with a competent pulmonary valve provides a satisfac-
ory solution, with excellent short-term results in terms of
entricular function and NYHA functional class (4,18).
lthough long-term results are also good for PVR, a
ubstantial number of patients still have adverse events
uring follow-up (7). In the current study, event-free
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Long-Term Outcome After PVR in TOF Patients October 26, 2010:1486–92urvival was 76% after 10 years, which is similar to that of
ther studies in which long-term survival after PVR was
eported (12,19). A number of factors that are important for
ost-PVR outcome have been identified. These mainly
nclude post-operative homograft-related factors such as
arly recurrence of PR or pulmonary stenosis (12,20).
nterestingly, in the study by Oosterhof et al. (12), which
as a large follow-up study that consisted of 158 adult TOF
atients who underwent PVR, neither the type of initial
OF correction nor the PVR surgical characteristics were
redictive of outcome after PVR. In that study, RV volumes
nd ejection fraction, assessed pre-operatively with cardio-
ascular magnetic resonance imaging, were not predictive of
ost-PVR outcome. Although it is known that QRS dura-
ion is strongly associated with outcome in TOF patients
10), no studies on the clinical application of QRS duration
or the assessment of post-PVR outcome are available. The
urrent study demonstrates that pre-operative QRS dura-
ion is associated with post-operative outcome. Longer
RS duration was significantly associated with increased
ncidence of adverse outcome after PVR. Furthermore,
evere QRS prolongation (180 ms) after PVR and the
bsence of a reduction in QRS duration demonstrated an
ven stronger association with post-operative outcome. As
e-PVR has an indirect association with ventricular function
12), separate Kaplan-Meier survival curves were obtained
Prediction of Outcome Using QRS DurationTable 2 Prediction of Outcome Using QRS D
Univa
HR
Pre-operative† 1.025‡
Pre-operative 180 ms 3.187‡
Post-operative† 1.026§
Post-operative 180 ms 4.668§
Change in QRS duration 0.978‡
No reduction in QRS duration 5.891§
*In themultivariatemodel, the hazard ratio (HR) was adjusted for age (bel
pulmonary valve replacement. †Hazard ratio per ms increase in QRS du
CI  confidence interval.
Observed Annualized Event Rate According to QTable 3 Observed Annualized Event Rate Ac
n Patient-
Overall 90 483
Pre-operative QRS duration
180 ms  PO QRS reduction 44 241
180 ms  PO QRS reduction 27 157
180 ms  PO QRS reduction 14 75
180 ms  PO QRS reduction 5 9
PO QRS duration
180 ms  PO QRS reduction 52 294
180 ms  PO QRS reduction 21 123
180 ms  PO QRS reduction 6 22
180 ms  PO QRS reduction 11 43*p  0.007 versus the overall group. †p  0.030 versus the overall group.
CI  confidence interval; NA  not applicable; PO  post-operative.n which re-PVR was excluded as an end point. That
onfirmed that QRS duration has a strong association with
ost-PVR outcome in patients with TOF.
The association between prolonged QRS duration and
atient outcome in TOF was first recognized by Gatzoulis
t al. (10). In a study on 178 adults with a previous total
epair for TOF, it was demonstrated that ventricular tachy-
ardia was associated with QRS prolongation beyond 180
s. In addition, it was shown that patients who had an
nlarged RV had a longer QRS duration. The relation
etween RV enlargement and QRS duration was confirmed
hereafter in study by Book et al. (21). They demonstrated
hat prolonged QRS duration (150 ms), had a positive
redictive value of 92% for the detection of RV dilation on
ardiovascular magnetic resonance imaging. Moreover, Nef-
ke et al. (22) demonstrated that QRS duration was also
orrelated to RV mass. In addition to the relation between
RS duration and ventricular function, it was shown in a
tudy Budts et al. (23) that lack of reduction in QRS
uration during exercise is significantly related to reduced
xercise capacity in adult TOF patients. Furthermore,
revious studies have indicated reduction of QRS duration
n response to PVR (8). This reduction in QRS duration
as related to the reduction in RV end-diastolic volume,
hich demonstrated that PVR improved the electrophysi-
logical characteristics of the RV. However, to date, it
on
Multivariate*
95% CI HR 95% CI
01–1.051 1.024‡ 1.000–1.049
07–10.084 3.408 0.969–11.982
11–1.043 1.024§ 1.008–1.041
61–14.914 3.685‡ 1.104–12.304
58–0.998 0.979‡ 0.959–0.999
85–21.894 6.767§ 1.704–26.878
ove themedian of 30 years) and concomitant surgical procedures during
‡p  0.05. §p  0.01. Hazard ratio per ms change in QRS duration.
urationing to QRS Duration
Events
Events/
100 Patient-Years 95% CI
13 2.7 1.4–4.6
0 0 NA
8 5.1 2.2–10.0
3 4.0 0.8–11.6
2 20.6 2.5–74.4*
2 0.7 0.1–2.4
6 4.9 1.8–10.6
1 4.5 0.1–24.9
4 9.3 2.5–23.8†urati
riate
1.0
1.0
1.0
1.4
0.9
1.5
owor abRS Dcord
Years
.8
.8
.0
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October 26, 2010:1486–92 Long-Term Outcome After PVR in TOF Patientsemained to be investigated whether these changes in
lectrophysiological characteristics were of relevance in
erms of clinical outcome.
The current study demonstrates for the first time that severe
RS prolongation (180 ms) either before or after PVR, or
he absence of a reduction in QRS duration after PVR, is
ssociated with the increased incidence of adverse outcome
uring long-term follow-up. It could be postulated that the
atients who lack improvement in QRS duration have a poorer
V condition and thus exhibit a higher risk for adverse events
Figure 3 Kaplan-Meier Survival Curves and QRS Duration
Kaplan-Meier survival curves for patient subgroups stratified by (A, B) before pulm
duration; and (E, F) 6-month post-operative QRS duration. Separate curves are pro
the result of the log-rank test. (A, B, E, F) QRS durations 180 ms are indicated
tions are indicated by green lines; no QRS reductions are indicated by blue lines.s compared with patients who improve in QRS duration after pVR. Analogous with this, the observation that longer QRS
uration before PVR was associated with increased incidence
f adverse events after PVR may also be related to a more
eteriorated RV condition already before PVR. That no events
ere observed in patients with a QRS duration180 ms who
emonstrated improvement of QRS duration after PVR may
eflect the other end of the same pathophysiological spectrum.
tudy limitations. As with most studies on patients with
ongenital heart disease, a limitation of the current study is
he relatively small number of patients. Therefore, a com-
valve replacement (PVR) QRS duration; (C, D) post-operative changes in QRS
in which re-PVR was excluded as an end point (B, D, F). The p values denote
en lines; QRS durations 180 ms are indicated by blue lines. (C, D) QRS reduc-onary
vided
by grerehensive multivariate Cox’s regression analysis, in which
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Long-Term Outcome After PVR in TOF Patients October 26, 2010:1486–92he HRs are adjusted for all possible confounders, could not
e obtained. Furthermore, the subgroup analysis based on
efore and after PVR QRS duration and changes after PVR
n QRS duration would benefit from a larger sample size, as
hat increases the precision of the event rate estimations. A
arge multicenter trial with sufficient power for a complete
nalysis of possible confounders is warranted to improve the
uantification of the event rates and to confirm the differ-
nces between the subgroups. In addition, that QRS dura-
ion was tested continuously as well as categorically using a
redefined cut off may introduce type I statistical error in
he current evaluation. However, a consistent association
etween QRS duration and patient outcome was observed
hether QRS duration was entered continuously or cate-
orically in the regression equation.
linical implications. The current study demonstrates
hat both QRS duration itself and the changes in QRS
uration after PVR can be used to identify patients who are
t increased risk for adverse events during follow-up after
VR. Therefore, the patients who have a QRS duration
180 ms either before or after PVR, and the patients who
o not demonstrate improvement of QRS duration after
VR, may require a vigilant follow-up regimen, as they
xhibit a high risk for adverse outcome. Currently, PVR is
ecommended when important PR and severe RV dilation
ccur, specifically when this coincides with reduced NYHA
unctional class (18,24). As the current study demonstrates
hat severely prolonged QRS duration (180 ms) is asso-
iated with increased incidence of adverse outcome, it could
e postulated that PVR should be performed before severe
RS prolongation occurs. The latter point, however, needs
o be confirmed in a sufficiently powered clinical trial.
onclusions
he QRS duration either before or after PVR and the
hanges in QRS duration after PVR are important deter-
inants of long-term outcome in adults with TOF and may
erve as an easy screening tool to identify patients at high
isk for adverse events after PVR.
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